Categories
Change Password!
Reset Password!
Mometasone–azelastine vs. fluticasone–azelastine n...
ENT experts release consensus on allergic rhinitis...
Allergic rhinitis (AR) is increasingly recognized as a chronic inflammatory airway disease rather than a benign nasal condition. With rising prev...
Tapinarof 1% shows strong safety profile in psoria...
A growing body of clinical and real-world evidence highlights tapinarof (aryl hydrocarbon receptor agonist) cream 1% as a well-tolerated and flex...
Saline rinse + Aze-Flu spray offers excellent reli...
According to the findings of a recent study, saline irrigation enhances the therapeutic effect of azelastine–fluticasone (Aze-Flu), leading...
Jueyin granules emerge as an effective complementa...
Psoriasis is a persistent, immune-driven inflammatory disorder, and traditional Chinese medicine (TCM) is increasingly recognized for its multi-t...
Identifying high-risk profiles for adverse events...
Peanut oral immunotherapy (OIT) helps reduce peanut allergy in many children, but it also triggers frequent reactions, especially during dose esc...
Azelastine + fluticasone nasal spray as prophylact...
Artemisia pollinosis contributes substantially to seasonal allergic rhinitis (SAR), where inadequate management during high-pollen periods increa...
On-demand vs. regular intranasal corticosteroid us...
As-needed intranasal corticosteroid (INCS) spray is frequently used by people suffering from allergic rhinitis (AR), especially when symptoms rem...
Tapinarof 1% offers clinically meaningful relief i...
Tapinarof 1% cream administered once per day remarkably improves disease severity and pruritus in atopic dermatitis (AD), according to the outcom...
Comparison of intranasal vs. oral therapies for AR...
Allergic rhinitis (AR) is a prevalent ailment typically managed with intranasal or oral medications.
